{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:17:11Z","timestamp":1778883431848,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23116"],"award-info":[{"award-number":["23116"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.trecan.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:58:27Z","timestamp":1630000707000},"page":"974-977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u03b2-Galactosylceramidase in cancer: friend or foe?"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-8376","authenticated-orcid":false,"given":"Marco","family":"Presta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2021.08.001_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2021.08.001_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2021.08.001_bb0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jnr.23873","article-title":"Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease","volume":"94","author":"Won","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.trecan.2021.08.001_bb0020","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1073\/pnas.1105639108","article-title":"Insights into Krabbe disease from structures of galactocerebrosidase","volume":"108","author":"Deane","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2021.08.001_bb0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbadis.2014.01.008","article-title":"Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease","volume":"1842","author":"Zizioli","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.trecan.2021.08.001_bb0030","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2021.08.001_bb0035","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/brain\/awt215","article-title":"Inhibition of angiogenesis by beta-galactosylceramidase deficiency in globoid cell leukodystrophy","volume":"136","author":"Belleri","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.trecan.2021.08.001_bb0040","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-19-3382","article-title":"beta-Galactosylceramidase promotes melanoma growth via modulation of ceramide metabolism","volume":"80","author":"Belleri","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2021.08.001_bb0045","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3892\/or.2015.4134","article-title":"GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.trecan.2021.08.001_bb0050","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.20172048","article-title":"Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-alphaVbeta5 axis","volume":"215","author":"Cao","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.trecan.2021.08.001_bb0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fonc.2020.00380","article-title":"GALC triggers tumorigenicity of colorectal cancer via senescent fibroblasts","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2021.08.001_bb0060","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41419-019-2117-9","article-title":"Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins","volume":"10","author":"Takeda","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2021.08.001_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/CBM-170995","article-title":"Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer","volume":"22","author":"Liu","year":"2018","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.trecan.2021.08.001_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2013.12.015","article-title":"Dividing cells regulate their lipid composition and localization","volume":"156","author":"Atilla-Gokcumen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2021.08.001_bb0075","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2326-6066.CIR-20-0342","article-title":"Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy","volume":"9","author":"Montfort","year":"2021","journal-title":"Cancer Immunol. Res."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803321001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803321001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:52:22Z","timestamp":1778881942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803321001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2405803321001606"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2021.08.001","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Galactosylceramidase in cancer: friend or foe?","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}